Michael Halstead, EVP and General Counsel: Intra-Cellular Therapies ITCI Sell · Filed 24/02/27

Trade details

Type: Insider sale
Amount: $501,731.1
Shares · price: 7,215 sh · $69.54 a share
Held after: 392 sh
Stock: Intra-Cellular Therapies ITCI
Person: Michael HalsteadEVP and General Counsel
Trade date: 24/02/26
Filed: 24/02/27
Days to filing: 1 days

Sold 94.8% of holdings

Share of holding sold: 94.8%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 24/01/27~24/03/27

Michael Halstead's recent trades

Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$1.3M
15,105 sh
$1.3M
Filed 24/11/14
Traded 24/11/12
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$1.2M
13,371 sh
$1.2M
Filed 24/11/14
Traded 24/11/13
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$548.2K
6,116 sh
$548.2K
Filed 24/11/14
Traded 24/11/12
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$475.1K
5,343 sh
$475.1K
Filed 24/11/14
Traded 24/11/13
Michael HalsteadPresident
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$149.8K
1,648 sh
$149.8K
Filed 24/11/14
Traded 24/11/12

Michael Halstead, EVP — sold $501.7K of Intra-Cellular Therapies ITCI · 94.8% of holdings · 10b5-1 plan | Whalegun